Hengliang Shi

机构：Xuzhou Medical College · ORCID：0000-0002-9649-1910

发表论文 63 篇 · 总被引 1015 次 · h-index 18

代表论文

• Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer (2023 · Clinical & Translational Oncology · 被引 28)
• Transcriptional regulator CTR9 promotes hepatocellular carcinoma progression and metastasis via increasing PEG10 transcriptional activity (2021 · Acta Pharmacologica Sinica · 被引 15)
• Effect of COP1 in Promoting the Tumorigenesis of Gastric Cancer by Down‐Regulation of CDH18 via PI3K/AKT Signal Pathway (2023 · Analytical Cellular Pathology · 被引 14)
• H19- and hsa-miR-338-3p-mediated NRP1 expression is an independent predictor of poor prognosis in glioblastoma (2021 · PLoS ONE · 被引 12)
• SIAH1/CTR9 axis promotes the epithelial–mesenchymal transition of hepatocellular carcinoma (2023 · Carcinogenesis · 被引 11)
• NUP37 accumulation mediated by TRIM28 enhances lipid synthesis to accelerate HCC progression (2024 · Oncogene · 被引 9)